|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-10-18
|
|
pubmed:abstractText |
The transfer of tumor suppressor genes has been shown to revert the malignant phenotype. In this regard, bax is a pro-apoptotic molecule that also functions as a tumor suppressor. The purpose of this study was to evaluate bax as a gene therapeutic in the context of cervical cancer.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 Academic Press.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
370-7
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11606099-Adenoviridae,
pubmed-meshheading:11606099-Apoptosis,
pubmed-meshheading:11606099-Female,
pubmed-meshheading:11606099-Gene Therapy,
pubmed-meshheading:11606099-Genes, Tumor Suppressor,
pubmed-meshheading:11606099-Genetic Vectors,
pubmed-meshheading:11606099-HeLa Cells,
pubmed-meshheading:11606099-Humans,
pubmed-meshheading:11606099-Proto-Oncogene Proteins,
pubmed-meshheading:11606099-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:11606099-Transduction, Genetic,
pubmed-meshheading:11606099-Tumor Cells, Cultured,
pubmed-meshheading:11606099-Uterine Cervical Neoplasms,
pubmed-meshheading:11606099-bcl-2-Associated X Protein
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 35249, USA. whuh@uab.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
